VitroLabs Patents – Insights & Stats (Updated 2023)

VitroLabs has a total of 31 patents globally, out of which 9 have been granted. Of these 31 patents, more than 87% patents are active. The USA is where VitroLabs has filed the maximum number of patents, followed by Australia. Parallelly, the USA seems to be the main focused R&D centre of VitroLabs and is also the origin country of the firm.

VitroLabs was founded in the year 2016 by Dusko Ilic and Ingvar Helgason. The company develops a platform that manufactures real leather using stem cell-based technologies.

Do read about some of the most popular patents of VitroLabs which have been covered by us in this article and also you can find VitroLabs patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over VitroLabs patent portfolio.

How many patents does VitroLabs have?

VitroLabs has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 27 patents are active.

How Many Patents did VitroLabs File Every Year?

VitroLabs Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVitroLabs Applications FiledVitroLabs Patents Granted
202262
202112
202071
201921
20181
201712
2016
2015

How many VitroLabs patents are Alive/Dead?

Worldwide Patents

VitroLabs Patent Portfolio

How Many Patents did VitroLabs File in Different Countries?

VitroLabs Worldwide Patent Filing

Where are Research Centres of VitroLabs Patents Located?

The R&D Centres of patents filed by VitroLabs is in the USA.

Most Cited VitroLabs Patent

US20190136060A1 is the most popular patent in the VitroLabs portfolio. It has received 16 citations so far from companies like Modern Meadow and Marathon Petroleum Company.

List of VitroLabs Patents

VitroLabs PatentsTitle
US11739217B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US11591471B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US11377559B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US11091639B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US10711136B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US10273549B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
US20230012452A1Scalable Bioreactor Systems And Methods For Tissue Engineering
EP4004180A4Scalable Bioreactor Systems And Methods For Tissue Engineering
EP3445866A4Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
CN116463278AEngineered Skin Equivalent, Method Of Manufacture And Products Derived Therefrom
CN109312381AEngineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
WO2022178441A1Immortalized Cell Line For Engineered Synthetic Leather
JP2023082100AEngineered Skin Equivalents, Methods Of Making Them And Products Derived Therefrom
CA3021688A1Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
AU2022200445B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
AU2017252443B2Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
AU2022222783A1Immortalized Cell Line For Engineered Synthetic Leather
AU2020322793A1Scalable Bioreactor Systems And Methods For Tissue Engineering
HK40075128AScalable Bioreactor Systems And Methods For Tissue Engineering
HK40004599AEngineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
SG11202200964RAScalable Bioreactor Systems And Methods For Tissue Engineering
GB2555149BEngineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
ZA202202433AScalable Bioreactor Systems And Methods For Tissue Engineering
BR112018071667A2Genetically Created Skin Equivalent, Method Of Its Manufacturing And Products Derived From It
RU2018140838A3Engineered Skin Equivalent, Method For Its Production And Products Derived From It
IN201817043296AEngineered Skin Equivalent Method Of Manufacture Thereof And Products Derived Therefrom
IL290238AScalable Bioreactor Systems And Methods For Tissue Engineering
US20190136060A1Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
WO2021021968A1Scalable Bioreactor Systems And Methods For Tissue Engineering
WO2017184967A1Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom
JP2019514423A5Engineered Skin Equivalents, Methods Of Making Them And Products Derived Therefrom

What are VitroLabs key innovation segments?

What Technologies are Covered by VitroLabs?

The chart below distributes patents filed by VitroLabs in different countries on the basis of the technology protected in patents. It also represents the markets where VitroLabs thinks it’s important to protect particular technology inventions.

R&D Focus: How has VitroLabs search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by VitroLabs?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.